ATMI has invested in sterile-connector and sterile-fill technology developed by Medical Instill Technologies.
ATMI, a provider of single-use bioprocess solutions, has invested in sterile connector and sterile fill technology developed by Medical Instill Technologies (Medinstill), a provider of transfer and packaging solutions for high purity fluids at unmatched safety levels.
The investments focus on the INTACT family of products developed by Medinstill. These technologies will be deployed in sterile filling, sterile multiple-dose dispensing, sterile transfer, and packaging sterilization solutions.
In other news, ATMI has introduced a line of pyrogen-free vials in collaboration with Disposable Lab, a Bordeaux, France contract manufacturing organization
Source: ATMI
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.